- Home
- Publications
- Publication Search
- Publication Details
Title
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 12, Pages 1833
Publisher
MDPI AG
Online
2019-11-22
DOI
10.3390/cancers11121833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The dawn of a new era in treating T-PLL
- (2019) Alexandra Schrader et al. Oncotarget
- High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
- (2019) Barbara Maurer et al. HAEMATOLOGICA
- Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation
- (2019) Alexandra Gomez-Arteaga et al. LEUKEMIA & LYMPHOMA
- Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL)
- (2019) Philipp B. Staber et al. BLOOD
- Janus Kinase Inhibition for Graft-Versus-Host Disease: Current Status and Future Prospects
- (2019) Daniele Mannina et al. DRUGS
- Structural and functional consequences of the STAT5BN642H driver mutation
- (2019) Elvin D. de Araujo et al. Nature Communications
- Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
- (2018) Liye He et al. CANCER RESEARCH
- Pharmacologic inhibition of STAT5 in acute myeloid leukemia
- (2018) Bettina Wingelhofer et al. LEUKEMIA
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
- (2018) A. Schrader et al. Nature Communications
- SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
- (2018) Patricia Johansson et al. Blood Cancer Journal
- Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review
- (2018) Waseem Lone et al. Current Hematologic Malignancy Reports
- STAT5BN642H is a driver mutation for T cell neoplasia
- (2017) Ha Thi Thanh Pham et al. JOURNAL OF CLINICAL INVESTIGATION
- Drug-perturbation-based stratification of blood cancer
- (2017) Sascha Dietrich et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
- (2017) E I Andersson et al. LEUKEMIA
- Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
- (2017) S Degryse et al. LEUKEMIA
- The Genetic Basis of Hepatosplenic T-cell Lymphoma
- (2017) Matthew McKinney et al. Cancer Discovery
- High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia
- (2016) E. I. Andersson et al. BLOOD
- Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
- (2016) Cristina López et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas
- (2016) A Nicolae et al. LEUKEMIA
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Genetic characterization of T-PLL reveals two major biologic subgroups andJAK3mutations as prognostic marker
- (2015) Anna Stengel et al. GENES CHROMOSOMES & CANCER
- Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
- (2015) C. Vicente et al. HAEMATOLOGICA
- Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
- (2015) Christian Prinz et al. Molecular Cancer
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome
- (2015) Mark J. Kiel et al. Nature Communications
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
- (2015) Can Küçük et al. Nature Communications
- Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
- (2015) Shuqun Yang et al. Oncotarget
- Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
- (2015) C. Vicente et al. HAEMATOLOGICA
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
- (2014) S. Degryse et al. BLOOD
- Identification of STAT5A and STAT5B Target Genes in Human T Cells
- (2014) Takahiro Kanai et al. PLoS One
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
- (2013) Georg Hopfinger et al. CANCER
- Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
- (2013) D Bellanger et al. LEUKEMIA
- Mature T-cell Lymphomagenesis Induced by Retroviral Insertional Activation of Janus Kinase 1
- (2013) Tim Heinrich et al. MOLECULAR THERAPY
- How I treat prolymphocytic leukemia
- (2012) C. Dearden BLOOD
- Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route
- (2011) C. E. Dearden et al. BLOOD
- Transforming JAK1 mutations exhibit differential signalling, FERM domain requirements and growth responses to interferon-γ
- (2010) Geoff M. Gordon et al. BIOCHEMICAL JOURNAL
- Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers
- (2009) Tekla Hornakova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started